Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8)
- PMID: 15649866
- DOI: 10.1124/jpet.104.080655
Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8)
Abstract
Relaxin family peptide 1 (RXFP1) receptor (LGR7) and RXFP2 receptor (LGR8) were recently identified as the receptor targets for H2 relaxin and insulin-like peptide 3 (INSL3), respectively. In this study, we define the pharmacology of these two receptors by using a number of receptor chimeras and relaxin family peptides. We have identified two binding sites on these receptors: one primary, high-affinity site within the ectodomain and a secondary, lower affinity site within the transmembrane region. The primary site was found to dictate receptor binding characteristics, although the lower affinity site also exerts some influence and modulates ligand affinity for the primary site in a manner dependent upon the peptide in question. Not all relaxin peptides were able to bind to the RXFP2 receptor, indicating that the relaxin-RXFP2 receptor interaction is species-specific. INSL3 was found to exhibit characteristics of a partial agonist at the RXFP2 and chimeric RXFP1/2 receptors, with low maximal cAMP responses but high potency in coupling to this pathway. cAMP accumulation studies also revealed that the binding sites couple to cAMP signaling pathways with differing efficiency: the high-affinity site signals with high efficiency, whereas the lower affinity site signals with little to no efficiency. Comparisons between RXFP1, RXFP2, the chimeric receptors, and the truncated receptors revealed that the interaction between receptor sites is critical for optimal ligand binding and signal transduction and that the ectodomain is essential for signaling. Evidence obtained in this study supports a two-stage binding model of receptor activation: binding to the primary site allows a conformational change and interaction with the low-affinity transmembrane site.
Similar articles
-
Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.Ann N Y Acad Sci. 2005 May;1041:17-21. doi: 10.1196/annals.1282.004. Ann N Y Acad Sci. 2005. PMID: 15956682
-
Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.Mol Pharmacol. 2009 Feb;75(2):415-28. doi: 10.1124/mol.108.051227. Epub 2008 Nov 24. Mol Pharmacol. 2009. PMID: 19029286
-
Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.Mol Pharmacol. 2006 Jul;70(1):214-26. doi: 10.1124/mol.105.021691. Epub 2006 Mar 28. Mol Pharmacol. 2006. PMID: 16569707
-
Relaxin-3, INSL5, and their receptors.Results Probl Cell Differ. 2008;46:213-37. doi: 10.1007/400_2007_055. Results Probl Cell Differ. 2008. PMID: 18236022 Review.
-
International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.Pharmacol Rev. 2006 Mar;58(1):7-31. doi: 10.1124/pr.58.1.9. Pharmacol Rev. 2006. PMID: 16507880 Review.
Cited by
-
Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.Sci Rep. 2016 Jul 11;6:29648. doi: 10.1038/srep29648. Sci Rep. 2016. PMID: 27404393 Free PMC article.
-
Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.Br J Pharmacol. 2012 Mar;165(6):1644-1658. doi: 10.1111/j.1476-5381.2011.01470.x. Br J Pharmacol. 2012. PMID: 21557732 Free PMC article. Review.
-
Multi-Component Mechanism of H2 Relaxin Binding to RXFP1 through NanoBRET Kinetic Analysis.iScience. 2019 Jan 25;11:93-113. doi: 10.1016/j.isci.2018.12.004. Epub 2018 Dec 10. iScience. 2019. PMID: 30594862 Free PMC article.
-
Familial bilateral cryptorchidism is caused by recessive variants in RXFP2.J Med Genet. 2019 Nov;56(11):727-733. doi: 10.1136/jmedgenet-2019-106203. Epub 2019 Jun 5. J Med Genet. 2019. PMID: 31167797 Free PMC article.
-
Development of a selective agonist for relaxin family peptide receptor 3.Sci Rep. 2017 Jun 12;7(1):3230. doi: 10.1038/s41598-017-03465-7. Sci Rep. 2017. PMID: 28607363 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases